Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2776
Mueller Water Products
MWA
$3.38B
| $933K | ﹤0.01% |
33,949
-227,596
| -87% | -$6.31M |
2016 Q2
39 quarters
|
|
2777
United Parks & Resorts
PRKS
$1.47B
| $932K | ﹤0.01% |
28,548
-37,299
| -57% | -$1.31M |
2013 Q2
51 quarters
|
|
2778
Immunocore
IMCR
$1.53B
| $932K | ﹤0.01% |
30,909
-72,344
| -70% | -$2.34M |
2022 Q1
16 quarters
|
|
2779
Summit Therapeutics
SMMT
$13.4B
| $931K | ﹤0.01% |
49,103
-289,287
| -85% | -$4.68M |
2022 Q1
16 quarters
|
|
2780
Freshworks
FRSH
$3.33B
| $930K | ﹤0.01% |
115,877
-259,700
| -69% | -$2.4M |
2022 Q1
16 quarters
|
|
2781
Rhythm Pharmaceuticals
RYTM
$6.39B
| $926K | ﹤0.01% |
10,652
-120,784
| -92% | -$11.7M |
2017 Q4
33 quarters
|
|
2782
Northwest Natural Holdings
NWN
$1.99B
| $926K | ﹤0.01% |
17,402
-55,466
| -76% | -$2.75M |
2013 Q2
51 quarters
|
|
2783
Structure Therapeutics
GPCR
$1.97B
| $925K | ﹤0.01% |
19,188
+11,355
| +145% | +$777K |
2023 Q2
11 quarters
|
|
|
JBGS
2784
JBG SMITH
JBGS
$619M
| $923K | ﹤0.01% |
63,157
-41,224
| -39% | -$657K |
2017 Q3
34 quarters
|
|
2785
CRA International
CRAI
$1.07B
| $920K | ﹤0.01% |
5,682
-6,342
| -53% | -$1.14M |
2013 Q2
51 quarters
|
|
2786
Mineralys Therapeutics
MLYS
$2.09B
| $918K | ﹤0.01% |
33,877
-189,406
| -85% | -$5.55M |
2023 Q1
12 quarters
|
|
|
UMH
2787
UMH Properties
UMH
$1.32B
| $916K | ﹤0.01% |
63,489
-103,135
| -62% | -$1.6M |
2019 Q1
28 quarters
|
|
2788
Beazer Homes USA
BZH
$891M
| $910K | ﹤0.01% |
47,311
-37,805
| -44% | -$873K |
2013 Q2
51 quarters
|
|
2789
Preferred Bank
PFBC
$1.26B
| $909K | ﹤0.01% |
10,026
-12,105
| -55% | -$1.1M |
2016 Q3
38 quarters
|
|
|
EQPT
2790
EquipmentShare.com Inc
EQPT
$4.69B
| $908K | ﹤0.01% |
+44,580
| New | +$1.27M |
2026 Q1
0 quarters
|
|
2791
Bank First Corp
BFC
$1.69B
| $908K | ﹤0.01% |
6,720
-11,484
| -63% | -$1.57M |
2019 Q2
27 quarters
|
|
|
BETA
2792
Beta Technologies Inc
BETA
$5.19B
| $901K | ﹤0.01% |
+61,300
| New | +$1.26M |
2026 Q1
0 quarters
|
|
2793
PUT
Albemarle
ALB
$12.3B
| $898K | ﹤0.01% |
5,000
-200,000
| -98% | -$34.1M |
2024 Q3
6 quarters
|
|
2794
Upbound Group
UPBD
$928M
| $897K | ﹤0.01% |
49,681
-71,865
| -59% | -$1.4M |
2013 Q2
51 quarters
|
|
2795
First Bancorp
FNLC
$386M
| $893K | ﹤0.01% |
31,860
-14,795
| -32% | -$411K |
2016 Q2
39 quarters
|
|
2796
Peoples Bancorp
PEBO
$1.35B
| $893K | ﹤0.01% |
27,159
-50,241
| -65% | -$1.62M |
2016 Q1
40 quarters
|
|
2797
BigBear.ai
BBAI
$1.27B
| $890K | ﹤0.01% |
252,765
-1,125,436
| -82% | -$5.23M |
2023 Q2
11 quarters
|
|
2798
Live Oak Bancshares
LOB
$1.7B
| $889K | ﹤0.01% |
26,873
-44,507
| -62% | -$1.64M |
2023 Q2
11 quarters
|
|
|
GENB
2799
Generate Biomedicines
GENB
$1.76B
| $886K | ﹤0.01% |
+70,894
| New | +$866K |
2026 Q1
0 quarters
|
|
|
FFIC
2800
DELISTED
Flushing Financial
FFIC
| $885K | ﹤0.01% |
57,646
-25,497
| -31% | -$399K |
2016 Q1
40 quarters
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.